Pluri announces leadership from business verticals to attend conferences

Pluri announced leadership from its business verticals will be presenting at, and participating in, the following conferences: Conference: MIW, Germany-Israel Technology. Michal Ogolnik, leader of Pluri’s cell-based coffee business, will be presenting at MIW. Pluri’s cell-based coffee business is part of its PluriAgtech business vertical, which deploys its world-leading 3D cell expansion technology platform to reshape the agricultural landscape and redefine the possibilities of sustainable crop production. Conference: ATiO Conference 2024. Pluri’s cell therapy product, PLX-PAD, will be evaluated as potential treatment for knee osteoarthritis as a part of the PROTO collaboration led by Charite Berlin and supported by the EU Horizon Europe program. Conference: Biomed Israel. Pluri’s leadership will attend the event. Conference: Bio International Convention. Recently launched in January of 2024, PluriCDMO helps innovative companies develop and manufacture life-changing therapies within the rapidly growing $5.2 billion cell and gene therapy sector by offering manufacturing support from the preclinical and development stages to late stage clinical and commercial production, including fill and finish and logistics.